ask="6.50"
ask_size="500"
average_daily_volume="203332"
bid="5.30"
bid_size="600"
book_value="3.19"
change="+0.05"
change_from_200_day_moving_average="-4.91"
change_from_50_day_moving_average="-1.22"
change_from_52_week_high="-12.00"
change_From_52_week_low="0.45"
change_in_percent="+0.88%"
close="5.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.47"
ebitda="-18.88M"
eps_estimate_current_year="-2.74"
eps_estimate_next_quarter="-0.91"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="5820000"
high="5.95"
high_52_weeks="17.70"
last_trade_date="1/3/2017"
last_trade_price="5.70"
last_trade_size="200"
last_trade_time="4:00pm"
low="5.55"
low_52_weeks="5.25"
market_capitalization="44.56M"
moving_average_200_day="10.61"
moving_average_50_day="6.92"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.69"
open="5.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-46.26%"
percent_change_from_50_day_moving_average="-17.64%"
percent_change_from_52_week_high="-67.80%"
percent_change_from_52_week_low="+8.57%"
previous_close="5.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="0.97"
stock_exchange="NCM"
symbol="TRIL"
volume="60369"
weeks_range_52="5.25 - 17.70"
